Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 2, 2011, Pages 341-351

  Watanaveeradej, Veerachai ^a   Simasathien, Sriluck ^a   Nisalak, Ananda ^b   Endy, Timothy P ^c   Jarman, Richard G ^b   Innis, Bruce L ^d   Thomas, Stephen J ^b   Gibbons, Robert V ^b   Hengprasert, Sumetha ^b   Samakoses, Rudiwilai ^a   Kerdpanich, Angkool ^a   Vaughn, David W ^d   Putnak, J Robert ^e   Eckels, Kenneth H ^e   De La Barrera, Rafael ^e   Mammen Jr , Mammen P ^f  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d GLAXOSMITHKLINE   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f US Army Medical Materiel Development Activity   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVE VACCINE; NEUTRALIZING ANTIBODY; PARACETAMOL; VARICELLA ZOSTER VACCINE;

ACUTE OTITIS MEDIA; ANOREXIA; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; DEHYDRATION; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE ESCALATION; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; ENCEPHALITIS VIRUS; ERYTHEMA; FACE RASH; FEBRILE CONVULSION; FEMALE; FEVER; FRACTURE; GASTRITIS; GASTROENTERITIS; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; IRRITABILITY; ISOLATED FEVER; LOW DRUG DOSE; MALE; NEUTROPENIA; PAIN; PARAINFLUENZA VIRUS 1; PHARYNGITIS; PHYSICAL ACTIVITY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SKIN REDNESS; SWELLING; TREATMENT RESPONSE; VACCINATION; VARICELLA ZOSTER VIRUS; VIREMIA; VOMITING;

DENGUE; DENGUE VACCINES; ENCEPHALITIS, JAPANESE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; JAPANESE ENCEPHALITIS VACCINES; VACCINES, ATTENUATED;

DENGUE VIRUS; FLAVIVIRUS; HAEMOPHILUS INFLUENZAE SEROTYPE B; JAPANESE ENCEPHALITIS VIRUS;

EID: 80051533204     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0501     Document Type: Article

References (20)

1. Forattini OP, 2003. Epidemiology and phylogenetic relationships of dengue viruses. Dengue Bull 27: 91-94. (Pubitemid 38854666)
2. Monath TP, 1994. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA 91: 2395-2400. (Pubitemid 24139356)
3. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A, 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9. (Pubitemid 30049026)
4. Chaudhry S, Swaminathan S, Khanna N, 2006. Viral genetics as a basis of dengue pathogenesis. Dengue Bull 30: 121-132. (Pubitemid 47489916)
5. Pediatric Dengue Vaccine Initiative (PDVI), 2010. Global Burden of Dengue. Available at: http://www.pdvi.org/about-dengue/GBD.asp. Accessed April 12, 2010.
6. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW, 2003. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68: 191-202. (Pubitemid 38240545)
7. World Health Organization, 2009. Fact Sheet Number 117. Geneva, Switzerland: World Health Organization.
8. Whitehead SS, Blaney JE, Durbin AP, Murphy BR, 2007. Prospects for a dengue virus vaccine. Nat Rev Microbiol 5: 518-528. (Pubitemid 46925380)
9. DeRoeck D, Deen J, Clemens JD, 2003. Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries. Vaccine 22: 121-129. (Pubitemid 37357159)
10. Eckels KH, Dubois DR, Putnak R, Vaughn DW, Innis BL, Henchal EA, Hoke CH Jr, 2003. Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys. Am J Trop Med Hyg 69: 12-16.
11. Innis BL, Eckels KH, 2003. Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command. Am J Trop Med Hyg 69: 1-4.
12. Simasathien S, Thomas SJ, Watanaveeradej V, Nisalak A, Barberousse C, Innis BL, Sun W, Putnak RJ, Eckels KH, Hutagalung Y, Gibbons RV, Zhang C, De La Berrera R, Jarman RG, Chawachalasai W, Mammen MP Jr, 2008. Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children. Am J Trop Med Hyg 78: 426-433. (Pubitemid 351845193)
13. Sun W, Cunningham D, Wasserman SS, Perry J, Putnak JR, Eckels KH, Vaughn DW, Thomas SJ, Kanesa-Thasan N, Innis BL, Edelman R, 2009. Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults. Hum Vaccin 5: 33-40.
14. Nutrition Division, Department of Health, Ministry of Public Health, 1999. National Growth References for Thai Children Under 20 Years of Age. Bangkok, Thailand: War Veterans Organization, 28-83.
15. Russell PK, Nisalak A, Suhhavachana P, Vivona S, 1967. A plaque reduction test for dengue neutralization antibodies. J Immunol 99: 285-290.
16. Klungthong C, Gibbons RV, Thaisomboonsuk B, Nisalak A, Kalayanarooj S, Thirawuth V, Nutkumhang N, Mammen MP Jr, Jarman RG, 2007. Dengue virus detection using whole blood for reverse transcriptase PCR and virus isolation. J Clin Microbiol 45: 2480-2485. (Pubitemid 47295477)
17. Sadon N, Delers A, Jarman RG, Klungthong C, Nisalak A, Gibbons RV, Vassilev V, 2008. A new quantitative RT-PCR method for sensitive detection of dengue virus in serum samples. J Virol Methods 153: 1-6.
18. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH Jr, 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis cocirculate. Am J Trop Med Hyg 40: 418-427. (Pubitemid 19117542)
19. International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Medical Dictionary for Regulatory Activities and Maintenance and Support Services Organization. Version 14.0 01, March 2011. Available at: http://www.meddramsso.com. Accessed May 26, 2011.
20. Watanaveeradej V, Endy TP, Samakoses R, Kerdpanich A, Simasathien S, Polprasert N, Aree C, Vaughn DW, Ho C, Nisalak A, 2002. Transplacentally transferred maternal-infant antibodies to dengue virus. Am J Trop Med Hyg 69: 123-128.